Bovine TB conference will address global issues
A conference will take place in Cardiff on June 16-19, to discuss the global problem of bovine TB.
Co-hosted by the British Cattle Veterinary Association (BCVA), the VI International Mycobacterium bovis (M bovis) Conference will be attended by international delegates from countries including Ethiopia and New Zealand.
The event, which moves across the world every four years, will maintain the core values of the previous conferences, which have seen it grow in global importance.
Attended by over 300 leading figures in the field and experts in animal and human health, the event will host discussions on a range of topics, and key note addresses will be delivered by scientific experts from across the world.
These speakers are all highly regarded in their fields, and will present on a range of subjects including TB epidemiology, vaccination, social science and economics, diagnostics, wildlife, policy options and practical delivery issues.
Professor Christianne Glossop, chief veterinary officer for Wales, said: “TB is one of the most serious animal health issues faced in Wales, and we have a commitment to eradicate it.
"I am delighted that the conference is coming to Wales. As well as learning from others from across the world, we are looking forward to sharing our eradication programme based on an annual testing regime, improved standards of biosecurity.
“Production systems and farming conditions may vary but the basic principles of infectious disease control are the same the world over and this is a fantastic opportunity for Wales and the UK.”
Among those in attendance will be research manager at New Zealand’s Animal Health Board and chair of the TB Control Programme Technical Advisory Group, Dr Paul Livingstone; head scientist at TB AHVLA, Professor Glyn Hewinson; and professor of veterinary epidemiology and risk assessment, Professor Simon More.
The full programme for the conference can be viewed here.
For more information please contact the BCVA Office by phoning 01452 725 735 or by email.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
